Latest News

Our research at the ICTMC Conference 2022
Hormone therapy can delay prostate cancer spread in people treated with surgery and radiotherapy
Adding abiraterone to standard therapy helps people with metastatic prostate cancer to live longer
The REFINE Trial is presented at the European Society for Medical Oncology Congress